JP2001507937A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001507937A5 JP2001507937A5 JP1998531037A JP53103798A JP2001507937A5 JP 2001507937 A5 JP2001507937 A5 JP 2001507937A5 JP 1998531037 A JP1998531037 A JP 1998531037A JP 53103798 A JP53103798 A JP 53103798A JP 2001507937 A5 JP2001507937 A5 JP 2001507937A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3549697P | 1997-01-14 | 1997-01-14 | |
| US60/035,496 | 1997-01-14 | ||
| PCT/US1998/000153 WO1998030694A2 (en) | 1997-01-14 | 1998-01-13 | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001507937A JP2001507937A (ja) | 2001-06-19 |
| JP2001507937A5 true JP2001507937A5 (cg-RX-API-DMAC7.html) | 2005-09-08 |
Family
ID=21883066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53103798A Withdrawn JP2001507937A (ja) | 1997-01-14 | 1998-01-13 | 腫瘍壊死因子レセプター６αおよび腫瘍壊死因子レセプター６β |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8003386B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1007659B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001507937A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20000070174A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1247567A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE365796T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU729062C (cg-RX-API-DMAC7.html) |
| BR (1) | BR9806954A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2277925A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69837996T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2286843T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998030694A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7597886B2 (en) | 1994-11-07 | 2009-10-06 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US7429646B1 (en) | 1995-06-05 | 2008-09-30 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor-like 2 |
| US7888466B2 (en) | 1996-01-11 | 2011-02-15 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HSATU68 |
| US7357927B2 (en) | 1996-03-12 | 2008-04-15 | Human Genome Sciences, Inc. | Death domain containing receptors |
| US6713061B1 (en) | 1996-03-12 | 2004-03-30 | Human Genome Sciences, Inc. | Death domain containing receptors |
| WO1997033904A1 (en) | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
| US7964190B2 (en) | 1996-03-22 | 2011-06-21 | Human Genome Sciences, Inc. | Methods and compositions for decreasing T-cell activity |
| US6635743B1 (en) | 1996-03-22 | 2003-10-21 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II and methods of use |
| US7285267B2 (en) | 1997-01-14 | 2007-10-23 | Human Genome Sciences, Inc. | Tumor necrosis factor receptors 6α & 6β |
| CN1247567A (zh) | 1997-01-14 | 2000-03-15 | 人体基因组科学有限公司 | 肿瘤坏死因子受体6α和6β |
| WO1999004001A1 (en) * | 1997-07-21 | 1999-01-28 | Zymogenetics, Inc. | Tumor necrosis factor receptor ztnfr-5 |
| WO1999007738A2 (en) * | 1997-08-06 | 1999-02-18 | Regeneron Pharmaceuticals, Inc. | Human orphan receptor ntr-1 |
| AU9376498A (en) * | 1997-09-05 | 1999-03-22 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
| IL134578A0 (en) * | 1997-09-18 | 2001-04-30 | Genentech Inc | DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| WO1999026977A1 (en) * | 1997-11-24 | 1999-06-03 | Biogen, Inc. | Novel receptors opg-2 |
| JP2002508168A (ja) * | 1997-12-16 | 2002-03-19 | インサイト・ファーマスーティカルズ・インコーポレイテッド | ヒト腫瘍壊死因子ｒ２様タンパク質 |
| DE19809978A1 (de) * | 1998-03-09 | 1999-09-16 | Basf Ag | Neuer Rezeptor aus der menschlichen Lunge |
| CZ20003433A3 (cs) * | 1998-03-30 | 2001-10-17 | Eli Lilly And Company | Terapeutické aplikace zralých FLINT (mFLINT) polypeptidů nebo OPG3, které jsou členy nadskupiny receptorů TNF |
| US6916907B1 (en) * | 1998-10-23 | 2005-07-12 | Curagen Corporation | Nucleic acids encoding osteoprotegern-like proteins and methods of using same |
| AU2164400A (en) * | 1998-12-09 | 2000-06-26 | Eli Lilly And Company | Flint compositions and uses thereof |
| WO2000037094A2 (en) * | 1998-12-22 | 2000-06-29 | Eli Lilly And Company | Therapeutic applications of flint polypeptides |
| WO2000046247A1 (en) * | 1999-02-05 | 2000-08-10 | Merck & Co., Inc. | Methods of use for dna molecules encoding m68, a tnf receptor-related protein |
| JP2002537769A (ja) | 1999-02-26 | 2002-11-12 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ヒトエンドカインαおよび使用方法 |
| EP1159286A4 (en) * | 1999-03-04 | 2003-01-15 | Human Genome Sciences Inc | TUMOR NECROSIS FACTOR RECEPTORS 6 ALPHA AND 6 BETA |
| AU2495200A (en) * | 1999-03-08 | 2000-09-28 | Genentech Inc. | Compositions and methods for the treatment of tumor |
| US6835814B1 (en) | 1999-03-30 | 2004-12-28 | Eli Lilly And Company | Protease resistant flint analogs |
| AU3739500A (en) * | 1999-03-30 | 2000-10-16 | Eli Lilly And Company | Protease resistant flint analogs |
| US6965012B1 (en) * | 1999-03-30 | 2005-11-15 | Eli Lilly And Company | Flint polypeptide analogs |
| JP2002539828A (ja) * | 1999-03-30 | 2002-11-26 | イーライ・リリー・アンド・カンパニー | Ｆｌｉｎｔポリペプチドアナログ |
| US6627199B1 (en) | 1999-07-09 | 2003-09-30 | Amgen Inc | Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family |
| WO2001010908A1 (en) * | 1999-08-04 | 2001-02-15 | Amgen Inc. | Ntr3, a member of the tnf-receptor supergene family |
| JP2003506088A (ja) | 1999-08-04 | 2003-02-18 | アムジェン インコーポレーテッド | ＴＮＦリガンドスーパー遺伝子ファミリーの新規のメンバーであるＦｈｍ |
| WO2001018055A1 (en) * | 1999-09-10 | 2001-03-15 | Eli Lilly And Company | Flint analog compounds and formulations thereof |
| WO2001018041A2 (en) * | 1999-09-10 | 2001-03-15 | Eli Lilly And Company | Flint proteins and formulations thereof |
| WO2001018202A2 (en) * | 1999-09-10 | 2001-03-15 | Eli Lilly And Company | Flint analog compounds and formulations thereof |
| WO2001096528A2 (en) | 2000-06-15 | 2001-12-20 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
| WO2002002641A1 (en) | 2000-06-16 | 2002-01-10 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to blys |
| CN1331125A (zh) * | 2000-06-26 | 2002-01-16 | 上海博德基因开发有限公司 | 一种新的多肽——人含细胞色素c结构域的tnfr/ngfr蛋白9.02和编码这种多肽的多核苷酸 |
| EP1322667A4 (en) * | 2000-08-25 | 2004-08-18 | Human Genome Sciences Inc | TUMOR NECROSIS FACTOR RECEPTORS 6-ALPHA AND 6-BETA |
| ES2437992T3 (es) | 2001-05-25 | 2014-01-15 | Human Genome Sciences, Inc. | Anticuerpos que se unen inmunoespecíficamente a los receptores de TRAIL |
| EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
| JP5303092B2 (ja) | 2002-09-11 | 2013-10-02 | ジェネンテック， インコーポレイテッド | タンパク質精製 |
| JP5905184B2 (ja) | 2005-10-13 | 2016-04-20 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッドＨｕｍａｎ Ｇｅｎｏｍｅ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． | 自己抗体陽性疾患を有する患者の処置に使用するための方法および組成物 |
| US20090269345A1 (en) * | 2005-12-23 | 2009-10-29 | Rong Fan | CLN248 Antibody Compositions and Methods of Use |
| US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| EP2406388B1 (en) * | 2009-03-13 | 2016-09-28 | The Trustees Of The University Of Pennsylvania | Ox40/trail fusion proteins |
| CN103874707B (zh) | 2010-11-19 | 2017-04-19 | 卫材R&D管理有限公司 | 中和抗‑ccl20抗体 |
| CA2908553A1 (en) | 2013-03-27 | 2014-10-02 | Cedars-Sinai Medical Center | Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways |
| CA2927309A1 (en) | 2013-05-24 | 2014-11-27 | Promis Neurosciences Inc. | Fasr antibodies for diagnostic and therapeutic use |
| EP4105236A1 (en) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease |
| JP7082945B2 (ja) | 2016-03-17 | 2022-06-09 | シーダーズ―シナイ メディカル センター | Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| CA2067031C (en) | 1991-04-26 | 2003-02-18 | Shigekazu Nagata | Dna coding for human cell surface antigen |
| JPH09503672A (ja) | 1993-10-14 | 1997-04-15 | イミュネックス・コーポレーション | Ｆａｓ拮抗剤とその利用 |
| US5830469A (en) | 1993-10-14 | 1998-11-03 | Immunex Corporation | Fas antagonists and uses thereof |
| US5663070A (en) | 1993-11-15 | 1997-09-02 | Lxr Biotechnology Inc. | Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| US5741667A (en) | 1994-05-27 | 1998-04-21 | Genentech, Inc. | Tumor necrosis factor receptor-associated factors |
| US5632994A (en) | 1994-06-14 | 1997-05-27 | La Jolla Cancer Research Foundation | Fas associated proteins |
| WO2000032221A2 (en) | 1998-12-01 | 2000-06-08 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
| EP2017337A1 (en) | 1995-04-27 | 2009-01-21 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptors |
| US5985614A (en) * | 1996-08-30 | 1999-11-16 | Human Genome Sciences, Inc. | Polynucleotides encoding interleukin-19 |
| CN1247567A (zh) | 1997-01-14 | 2000-03-15 | 人体基因组科学有限公司 | 肿瘤坏死因子受体6α和6β |
| US5885800A (en) | 1997-02-04 | 1999-03-23 | Smithkline Beecham Corporation | DNA encoding tumor necrosis related receptor, TR4 |
| WO1998056892A1 (en) | 1997-06-11 | 1998-12-17 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr9 |
| WO1999004001A1 (en) | 1997-07-21 | 1999-01-28 | Zymogenetics, Inc. | Tumor necrosis factor receptor ztnfr-5 |
| WO1999007738A2 (en) | 1997-08-06 | 1999-02-18 | Regeneron Pharmaceuticals, Inc. | Human orphan receptor ntr-1 |
| AU9376498A (en) | 1997-09-05 | 1999-03-22 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
| IL134578A0 (en) | 1997-09-18 | 2001-04-30 | Genentech Inc | DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| WO1999026977A1 (en) | 1997-11-24 | 1999-06-03 | Biogen, Inc. | Novel receptors opg-2 |
| JP2002508168A (ja) | 1997-12-16 | 2002-03-19 | インサイト・ファーマスーティカルズ・インコーポレイテッド | ヒト腫瘍壊死因子ｒ２様タンパク質 |
| AU2093499A (en) | 1997-12-30 | 1999-07-19 | Chiron Corporation | Members of tnf and tnfr families |
| US6297367B1 (en) | 1997-12-30 | 2001-10-02 | Chiron Corporation | Polynucleotide encoding TNFL1 |
| DE19809978A1 (de) | 1998-03-09 | 1999-09-16 | Basf Ag | Neuer Rezeptor aus der menschlichen Lunge |
| CZ20003433A3 (cs) | 1998-03-30 | 2001-10-17 | Eli Lilly And Company | Terapeutické aplikace zralých FLINT (mFLINT) polypeptidů nebo OPG3, které jsou členy nadskupiny receptorů TNF |
| JP2002519062A (ja) | 1998-07-06 | 2002-07-02 | シェーリング コーポレイション | 哺乳動物遺伝子；樹状細胞プロスタグランジン様トランスポーター（ｄｃ−ｐｇｔ）、ｈｄｔｅａ，ｈｓｌｊｄ３７ｒおよびｒａｎｋｌ、ｈｃｃ５ケモカイン、脱ユビキチン化１１および１２（ｄｕｂ１１、ｄｕｂ１２）、ｍｄ−１、ｍｄ−２およびサイクリンｅ２、関連試薬および方法 |
| AU2164400A (en) | 1998-12-09 | 2000-06-26 | Eli Lilly And Company | Flint compositions and uses thereof |
| WO2000037094A2 (en) | 1998-12-22 | 2000-06-29 | Eli Lilly And Company | Therapeutic applications of flint polypeptides |
| WO2000046247A1 (en) | 1999-02-05 | 2000-08-10 | Merck & Co., Inc. | Methods of use for dna molecules encoding m68, a tnf receptor-related protein |
| EP1159286A4 (en) | 1999-03-04 | 2003-01-15 | Human Genome Sciences Inc | TUMOR NECROSIS FACTOR RECEPTORS 6 ALPHA AND 6 BETA |
| CA2362427A1 (en) | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| AU2495200A (en) | 1999-03-08 | 2000-09-28 | Genentech Inc. | Compositions and methods for the treatment of tumor |
| WO2000053223A1 (en) | 1999-03-11 | 2000-09-14 | Human Genome Sciences, Inc. | Apoptosis inducing molecule ii and methods of use |
| JP2002539828A (ja) | 1999-03-30 | 2002-11-26 | イーライ・リリー・アンド・カンパニー | Ｆｌｉｎｔポリペプチドアナログ |
| AU3739500A (en) | 1999-03-30 | 2000-10-16 | Eli Lilly And Company | Protease resistant flint analogs |
| WO2001022920A2 (en) | 1999-09-29 | 2001-04-05 | Human Genome Sciences, Inc. | Colon and colon cancer associated polynucleotides and polypeptides |
| AU1189101A (en) | 1999-10-20 | 2001-04-30 | Eli Lilly And Company | Therapeutic applications of flint polypeptides |
| AU1915201A (en) | 1999-12-07 | 2001-06-18 | Eli Lilly And Company | Improving stability of flint through o-linked glycosylation |
| EP1240311A1 (en) | 1999-12-09 | 2002-09-18 | Merck & Co., Inc. | Dna molecules encoding human nhl, a dna helicase |
| US20040048254A1 (en) | 2000-03-15 | 2004-03-11 | Alexander Olek | Diagnosis of diseases associated with tumor supressor genes and oncogenes |
| WO2002000677A1 (en) | 2000-06-07 | 2002-01-03 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| EP1294947A2 (en) | 2000-06-30 | 2003-03-26 | Epigenomics AG | Method and nucleic acids for pharmacogenomic methylation analysis |
| WO2002009668A2 (en) | 2000-08-02 | 2002-02-07 | Eli Lilly And Company | Pulmonary administration of flint |
| US20030073144A1 (en) | 2001-01-30 | 2003-04-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| AU2002246967A1 (en) | 2001-02-01 | 2002-08-12 | Eli Lilly And Company | Glycoforms a fas ligand inhibitory protein analog |
| US20040176279A1 (en) | 2001-02-01 | 2004-09-09 | Nigel Jenkins | Flint glycoforms |
| US20040236091A1 (en) | 2001-03-28 | 2004-11-25 | Chicz Roman M. | Translational profiling |
| FR2908832B1 (fr) | 2006-11-20 | 2011-08-26 | Valeo Systemes Thermiques | Carter pour echangeur de chaleur |
-
1998
- 1998-01-13 CN CN98801836A patent/CN1247567A/zh active Pending
- 1998-01-13 WO PCT/US1998/000153 patent/WO1998030694A2/en not_active Ceased
- 1998-01-13 ES ES98901699T patent/ES2286843T3/es not_active Expired - Lifetime
- 1998-01-13 DE DE69837996T patent/DE69837996T2/de not_active Expired - Fee Related
- 1998-01-13 CA CA002277925A patent/CA2277925A1/en not_active Abandoned
- 1998-01-13 US US09/006,352 patent/US8003386B1/en active Active
- 1998-01-13 BR BR9806954A patent/BR9806954A/pt not_active IP Right Cessation
- 1998-01-13 AU AU58157/98A patent/AU729062C/en not_active Ceased
- 1998-01-13 KR KR1019997006400A patent/KR20000070174A/ko not_active Ceased
- 1998-01-13 JP JP53103798A patent/JP2001507937A/ja not_active Withdrawn
- 1998-01-13 EP EP98901699A patent/EP1007659B1/en not_active Expired - Lifetime
- 1998-01-13 AT AT98901699T patent/ATE365796T1/de not_active IP Right Cessation
-
2000
- 2000-03-03 US US09/518,931 patent/US7186800B1/en not_active Expired - Lifetime